Rezolute (RZLT) Current Leases (2014 - 2026)
Rezolute (RZLT) posted Current Leases of $673000.0 for Q1 2026, up 1.05% sequentially from $666000.0 in Q4 2025, and up 9.43% YoY from $615000.0 in Q1 2025.
Rezolute (RZLT) Current Leases (2014 - 2026) Analysis & Trends
Rezolute has reported Current Leases for 11 years, with the latest figure at $673000.0 in Q1 2026.
- Quarterly Current Leases rose 9.43% year-over-year to $673000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $673000.0 (up 9.43% YoY) and the FY2025 annual result came in at $632000.0, up 11.27% from the prior year.
- Current Leases rose to $673000.0 in Q1 2026 per RZLT's latest filing, from $666000.0 in the prior quarter.
- Over five years, Current Leases peaked at $673000.0 in Q1 2026 and troughed at $107000.0 in Q1 2022.
- A 5-year average of $468000.0 and a median of $552000.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases sank 66.67% in 2022, then soared 400.93% in 2023.
- Over 5 years, Current Leases stood at $167000.0 in 2022, then jumped by 222.16% to $538000.0 in 2023, then rose by 11.34% to $599000.0 in 2024, then advanced by 11.19% to $666000.0 in 2025, then grew by 1.05% to $673000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $673000.0, $666000.0, and $650000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 673,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 673,000.00 |
| Dec 31, 2025 | 666,000.00 |
| Sep 30, 2025 | 650,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | 615,000.00 |
| Dec 31, 2024 | 599,000.00 |
| Sep 30, 2024 | 584,000.00 |
| Jun 30, 2024 | 568,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Dec 31, 2023 | 538,000.00 |
| Sep 30, 2023 | 525,000.00 |
| Jun 30, 2023 | 541,000.00 |
| Mar 31, 2023 | 319,000.00 |
| Dec 31, 2022 | 167,000.00 |
| Sep 30, 2022 | 112,000.00 |
| Jun 30, 2022 | 108,000.00 |
| Mar 31, 2022 | 107,000.00 |
| Dec 31, 2021 | 147,000.00 |
| Sep 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 265,000.00 |